Lv51
1400 积分 2023-09-06 加入
Standardization of Myasthenia Gravis Outcome Measures in Clinical Practice. A Report of the MGFA Task Force
1小时前
已完结
Non-ICANS neurological complications after CAR T-cell therapies: recommendations from the EBMT Practice Harmonisation and Guidelines Committee
1小时前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
9天前
已完结
Interstitial lung diseases
29天前
已完结
Interstitial lung disease in connective tissue disease—mechanisms and management
29天前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
1个月前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
1个月前
已完结
Opportunities and challenges of bi-specific antibodies
1个月前
已完结
Bispecific T cell engager therapy for refractory rheumatoid arthritis
1个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
1个月前
已完结
皖公网安备34019202002308
